Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
India boasts the largest livestock population, with 536 million livestock and 851 million poultry
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
PICCOLO trial met its primary endpoint of objective response rate (ORR)
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
Subscribe To Our Newsletter & Stay Updated